Information on PSCI and resource materials on pharmaceutical supply chain sustainability
The resources are particularly targeted at companies working in the supply chain – our suppliers – who are warmly encouraged to make free use of all the materials here.
We will continue to build this section over time. If you have any suggestions on how we can improve it please contact us.
Search for a resource by typing a word or phrase into the search box.
Filter by topic, target audience and category by clicking each of the filter buttons and choosing a filter from the list that appears. Show me
Full PSCI SAQ & Audit Report Template for Core Suppliers, External Manufacturers, Component and Material Suppliers (WORD VERSION)
PSCI Self Assessment Questionnaire and Audit Report Template for Core Suppliers, External Manufacturers, Component and Material Suppliers
Version 5, February 2019
Chinese translation uploaded August 2019.
Abbreviated PSCI SAQ & Audit Report Template for Service Providers & General Manufacturers (WORD VERSION)
Abbreviated PSCI Self Assessment Questionnaire & Audit Report Template for Service Providers & General Manufacturers.
Version 5, February 2019
The UK Bribery Act, which was passed in 2010, introduces an offence of corporate failure to prevent bribery. The defence for a company against this liability is to prove that it had adequate procedures in place to prevent bribery. This Guidance from Transparency International UK (TI-UK) is designed to assist companies to comply with the Bribery Act by providing clear, practical advice on good practice anti-bribery systems that in TI-UK's opinion constitute 'adequate procedures' for compliance with the Bribery Act.
The link provides Bayer’s principles for animal welfare and animal testing and their responsibility for the safety of our products and thus for people, animals and the environment, and the well-being of laboratory animals.
The Implementation Guidance Document provides examples of business practices and performance related to the Principles.
The Pharmaceutical Industry Principles for Responsible Supply Chain Management set the standard for ethics, labor, health and safety, environment and related management systems. The Principles may be voluntarily supported by any business in the pharmaceutical industry.
This Code of Ethics defines Sanofi-Aventis expectations when conducting business. It is provided as a resource to guide its employees in dealing with issues, both inside and outside the Group, that may be encountered as part of day to day functional responsibilities.
Guidance about procedures which relevant commercial organisations can put into place to prevent persons associated with them from bribing.
The sanofi-aventis charter: The purpose of the Supplier Relationships Charter is to clarify the rules of conduct that must be respected by all Group collaborators in their relations with suppliers. The Charter supplements the Group’s Code of Ethics, in particular as concerns the Group’s image and reputation, integrity, ethical conduct and freedom from conflicts of interest. The Charter defines and sets Procurement rules of conduct that must be respected by all Group employees at all points of interaction with suppliers.
The UN Global Compact’s Fighting Corruption in the Supply Chain: A Guide for Customers and Suppliers outlines why businesses must join the fight against corruption and provides pragmatic advice on addressing this complex challenge.
The Roche Group Code of Conduct is designed to guide business behaviour and provides useful links to further information.
Bioethics at Novo Nordisk. It is the expression used for all ethical issues related to the use of life science technologies in the discovery, development and production of pharmaceutical products. This covers the ethical aspects of the use of human biological material, animals and gene technology in research, and clinical trials.